Correlation Between Veracyte and EnGene Holdings

Can any of the company-specific risk be diversified away by investing in both Veracyte and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Veracyte and enGene Holdings Common, you can compare the effects of market volatilities on Veracyte and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and EnGene Holdings.

Diversification Opportunities for Veracyte and EnGene Holdings

-0.46

Correlation Coefficient

Veracyte  EnGene Holdings

Very good diversification

The 3 months correlation between Veracyte and EnGene is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Veracyte i.e., Veracyte and EnGene Holdings go up and down completely randomly.

Pair Corralation between Veracyte and EnGene Holdings

Given the investment horizon of 90 days Veracyte is expected to generate 0.26 times more return on investment than EnGene Holdings. However, Veracyte is 3.91 times less risky than EnGene Holdings. It trades about 0.15 of its potential returns per unit of risk. enGene Holdings Common is currently generating about 0.01 per unit of risk. If you would invest  3,245  in Veracyte on October 23, 2024 and sell it today you would earn a total of  813.00  from holding Veracyte or generate 25.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

Veracyte  vs.  enGene Holdings Common

Veracyte

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.

enGene Holdings Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days enGene Holdings Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, EnGene Holdings is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Veracyte and EnGene Holdings

The main advantage of trading using opposite Veracyte and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.

The idea behind Veracyte and enGene Holdings Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.